Prosecution Insights
Last updated: May 29, 2026

Tel Hashomer Medical Research Infrastructure And Services Ltd.

8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
6
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
1
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 7 days (1)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (12%)
6
Medium (75%)
0
Easy (0%)
1
Unknown (12%)

Rejection Statute Mix

BucketCases
§101 only1 (12%)
§103 only5 (62%)
§102 only1 (12%)
No statute on record1 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
38% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ELSHAER, ALAAELDIN M 1 36.0% +31.8%
BECKHARDT, LYNDSEY MARIE 1 28.2% +48.7%
ROZOF, TIMOTHY R 1 72.6% +24.0%
MIANO, JOSEPH PAUL 1 37.9% +63.3%
DAUNER, JOSEPH G 1 56.8% +34.8%
STEELE, AMBER D 1 59.1% +9.1%
FREDRICKSON, COURTNEY B 1 75.6% +30.7%
SMITH, PETER DANIEL 1 49.2% +50.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18270852 AURICULAR RECONSTRUCTION USING 3D PRINTED AUTOLOGOUS CARTILAGE TISSUE BECKHARDT, LYNDSEY MARIE 28d overdue
18280254 MACHINE LEARNING MODELS FOR PREDICTION OF UNPLANNED CESAREAN DELIVERY ELSHAER, ALAAELDIN M 14d

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17416508 SIMULTANEOUS ECMO AND CRRT SMITH, PETER DANIEL 86d overdue
18249469 URINE-DERIVED EPITHELIAL CELL CULTURES, NEPHROSPHEROIDS DERIVED THEREFROM AND METHODS OF PRODUCING AND USING SAME MIANO, JOSEPH PAUL 31d overdue
18130852 MARKER FOR RESPONSE TO PD-1/PD-L1 IMMUNOTHERAPY DAUNER, JOSEPH G 30d overdue
18270852 AURICULAR RECONSTRUCTION USING 3D PRINTED AUTOLOGOUS CARTILAGE TISSUE BECKHARDT, LYNDSEY MARIE 28d overdue
18256747 COMPOUNDS FOR TREATING EYE DISEASES AND DISORDERS ROZOF, TIMOTHY R 5d
18280254 MACHINE LEARNING MODELS FOR PREDICTION OF UNPLANNED CESAREAN DELIVERY ELSHAER, ALAAELDIN M 14d
17391227 METHOD FOR DELIVERY OF COMPOSITIONS TO THE EYE FREDRICKSON, COURTNEY B 39d

Top Art Units

Art UnitApps
3687 1
1613 1
1625 1
1631 1
1682 1
1658 1
3783 1
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18280254 MACHINE LEARNING MODELS FOR PREDICTION OF UNPLANNED CESAREAN DELIVERY ELSHAER, ALAAELDIN M 3687 §101 Non-Final OA 14d Pending Sep 04, 2023
18270852 AURICULAR RECONSTRUCTION USING 3D PRINTED AUTOLOGOUS CARTILAGE TISSUE BECKHARDT, LYNDSEY MARIE 1613 §103 Non-Final OA 28d overdue Pending Jul 04, 2023
18256747 COMPOUNDS FOR TREATING EYE DISEASES AND DISORDERS ROZOF, TIMOTHY R 1625 §102 Non-Final OA 5d Pending Jun 09, 2023
18249469 URINE-DERIVED EPITHELIAL CELL CULTURES, NEPHROSPHEROIDS DERIVED THEREFROM AND METHODS OF PRODUCING AND USING SAME MIANO, JOSEPH PAUL 1631 §103 Non-Final OA 31d overdue Pending Apr 18, 2023
18130852 MARKER FOR RESPONSE TO PD-1/PD-L1 IMMUNOTHERAPY DAUNER, JOSEPH G 1682 §103 Non-Final OA 30d overdue Pending Apr 04, 2023
17989817 TARGETING G3BP AGGREGATION TO PREVENT NEURODEGENERATION STEELE, AMBER D 1658 Other Non-Final OA 51d overdue Pending Nov 18, 2022
17391227 METHOD FOR DELIVERY OF COMPOSITIONS TO THE EYE FREDRICKSON, COURTNEY B 3783 §103 Final Rejection 39d Pending Aug 02, 2021
17416508 SIMULTANEOUS ECMO AND CRRT SMITH, PETER DANIEL 3781 §103 Final Rejection 86d overdue Pending Jun 20, 2021

Managing Tel Hashomer Medical Research Infrastructure And Services Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month